Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer

Woess, K; Sun, Y; Morio, H; Stierschneider, A; Kaufmann, A; Hainzl, S; Trattner, L; Kocher, T; Tockner, B; Leb-Reichl, V; Steiner, M; Brachtl, G; South, AP; Bauer, JW; Reichelt, J; Furihata, T; Wally, V; Koller, U; Piñón Hofbauer, J; Guttmann-Gruber, C; Int J Mol Sci. 2022; 23(1):

Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group.

Diallo, A; Troseid, M; Simensen, VC; Boston, A; Demotes, J; Olsen, IC; Chung, F; Paiva, JA; Hites, M; Ader, F; Arribas, JR; Baratt-Due, A; Melien, O; Tacconelli, E; Staub, T; Greil, R; Tsiodras, S; Briel, M; Esperou, H; Mentre, F; Eustace, J; Saillard, J; Delmas, C; LeMestre, S; Dumousseaux, M; Costagliola, D; Rottingen, JA; Yazdanpanah, Y CLIN MICROBIOL INFEC. 2022; 28(1): 1-5.

Neoadjuvant versus adjuvant management of resectable pancreas cancer: A review of the literature

Schlick, K MEMO-MAG EUR MED ONC. 2022;

Adverse Events in 1406 Patients Receiving 13,780 Cycles of Azacitidine within the Austrian Registry of Hypomethylating Agents-A Prospective Cohort Study of the AGMT Study-Group

Leisch, M; Pfeilstocker, M; Stauder, R; Heibl, S; Sill, H; Girschikofsky, M; Stampfl-Mattersberger, M; Tinchon, C; Hartmann, B; Petzer, A; Schreder, M; Kiesl, D; Vallet, S; Egle, A; Melchardt, T; Piringer, G; Zebisch, A; Machherndl-Spandl, S; Wolf, D; Keil, F; Drost, M; Greil, R; Pleyer, L CANCERS. 2022; 14(10): 2459

The CIRCULATE Trial: Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation (AIO-KRK-0217)

Folprecht, G; Reinacher-Schick, A; Weitz, J; Lugnier, C; Kraeft, AL; Wisser, S; Aust, DE; Weiss, L; von Bubnoff, N; Kramer, M; Thiede, C; Tannapfel, A CLIN COLORECTAL CANC. 2022; 21(2): 170-174.

DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma

Starzer, AM; Heller, G; Tomasich, E; Melchardt, T; Feldmann, K; Hatziioannou, T; Traint, S; Minichsdorfer, C; Schwarz-Nemec, U; Nackenhorst, M; Mullauer, L; Preusser, M; Berghoff, AS; Fuereder, T J IMMUNOTHER CANCER. 2022; 10(3): e003420

Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma

Bishop, MR; Dickinson, M; Purtill, D; Barba, P; Santoro, A; Hamad, N; Kato, K; Sureda, A; Greil, R; Thieblemont, C; Morschhauser, F; Janz, M; Flinn, I; Rabitsch, W; Kwong, YL; Kersten, MJ; Minnema, MC; Holte, H; Chan, EHL; Martinez-Lopez, J; Muller, AMS; Maziarz, RT; McGuirk, JP; Bachy, E; Le Gouill, S; Dreyling, M; Harigae, H; Bond, D; Andreadis, C; McSweeney, P; Kharfan-Dabaja, M; Newsome, S; Degtyarev, E; Awasthi, R; del Corral, C; Andreola, G; Masood, A; Schuster, SJ; Jager, U; Borchmann, P; Westin, JR NEW ENGL J MED. 2022;

Kindlin-3 maintains marginal zone B cells but confines follicular B cell activation and differentiation

Harzschel, A; Li, LX; Krenn, PW; Szenes-Nagy, E; Andrieux, G; Bayer, E; Pfeifer, D; Polcik, L; Denk, U; Hopner, JP; Karabatak, E; Danner, DJ; Tangermann, S; Kenner, L; Jumaa, H; Greil, R; Borries, M; Ruppert, R; Maity, PC; Hartmann, TN J LEUKOCYTE BIOL. 2022;

Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

Tilly, H; Morschhauser, F; Sehn, LH; Friedberg, JW; Trneny, M; Sharman, JP; Herbaux, C; Burke, JM; Matasar, M; Rai, S; Izutsu, K; Mehta-Shah, N; Oberic, L; Chauchet, A; Jurczak, W; Song, YQ; Greil, R; Mykhalska, L; Bergua-Burgues, JM; Cheung, MC; Pinto, A; Shin, HJ; Hapgood, G; Munhoz, E; Abrisqueta, P; Gau, JP; Hirata, J; Jiang, YW; Yan, M; Lee, C; Flowers, CR; Salles, G NEW ENGL J MED. 2022;

Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-Paclitaxel.

Riedl, JM; Schwarzenbacher, E; Moik, F; Horvath, L; Gantschnigg, A; Renneberg, F; Posch, F; Barth, DA; Stotz, M; Pichler, M; Hatzl, S; Fandler-Hofler, S; Gressenberger, P; Gary, T; Jost, PJ; Greil, R; Ay, C; Djanani, A; Gerger, A; Schlick, K Thromb Haemost. 2022; 122(4):633-645